🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Brookdale Senior Living Inc. BKD R2K

Healthcare · Medical Care Facilities · United States
https://www.brookdale.com
Company Profile ↓
$14.19
+78.49% 1Y
Mkt Cap$3.39B
P/E-16.31
P/B-57.39
52W High$16.77
52W Low$7.13
Book Value$-0.23
EPS (TTM)$-0.87

Company Overview

Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.

Recent Developments

  • Dec 2025 Revenue of $3.19B (+2.2% YoY); net profit $-262.69M.
  • Trailing 12 Months Year-on-year growth — revenue -6.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 3.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:3.01%
1 Year:-6.70%

Stock Price Performance

1 Year:+78.49%
6 Months:+28.88%
3 Months:+4.34%
1 Month:+9.66%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 73% of range
$7.13 $16.77
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)46.29 · Neutral
Price Performance
1M+9.66%
3M+4.34%
6M+28.88%
1Y+78.49%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-16.31
Industry PE
25.41
Forward P/E
129.00
PEG Ratio
0.28
Book Value
$-0.23
Price to Book
-57.39
P/S
1.07
EV/EBITDA
18.20
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
3.01%
Profit 5Y
-
Revenue (YoY)
-6.70%
Earnings (YoY)
-

Profitability & Returns

ROCE
0.25%
ROE
-
ROA
1.30%
Profit Margin
-6.82%
Op Margin
7.51%
Gross Margin
27.95%
EPS (Latest Qtr)
$-0.03
EPS (TTM)
$-0.87

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
0.63
Current Ratio
1.03
Debt
$5.51B
Total Assets
$5.90B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
1.96%
Chg in Prom Hold
-
FII / Inst Holding
112.89%
Chg in FII Hold
-0.08%

Financial Snapshot

Enterprise Value
$3.39B
Total Revenue (TTM)
$3.00B
EBITDA
$464.31M
Free Cash Flow
$-1.92M
Operating Cash Flow
$215.52M
Shares Outstanding
238.82M
Gross Margin
27.95%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 BKD Brookdale Senior Living Inc. R2K 14.19 -16.31 $3.39B 0.00% 0.25% - 3.01% -
2 LLY Eli Lilly and Company SPX 1,152.54 41.02 $1.03T 0.61% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 253.85 29.45 $611.07B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.78 119.40 $432.48B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 425.19 32.02 $386.13B 2.27% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 120.78 34.02 $298.31B 2.86% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 164.50 24.81 $255.12B 1.77% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 534.07 29.33 $198.47B 0.40% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 355.25 24.69 $191.73B 2.84% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue -------------1.19B1.16B1.12B-1.04B1.02B1.01B-1.01B865.91M807.98M749.45M723.29M641.65M677.82M689.52M757.46M753.26M750.79M757.29M782.83M777.54M784.17M813.86M812.94M813.16M764.86M
Gross Profit -370.44M363.83M355.06M-362.03M379.65M354.14M-358.28M314.11M290.38M-292.62M285.96M251.63M-239.13M227.07M199.08M-302.94M158.36M146.68M127.34M129.44M123.38M127.92M138.46M194.46M187.50M185.68M184.90M204.31M204.82M198.12M223.09M215.92M210.85M216.36M
Operating Income -74.51M-116.87M-43.12M3.66M-8.87M41.35M58.29M47.65M-178.37M48.13M30.17M-350.97M2.62M-413.83M-137.59M3.63M-46.45M16.66M2.21M-20.22M-43.15M14.90M-59.98M-55.12M-61.59M-52.49M-48.85M-53.53M-34.05M19.21M7.82M41.16M-6.34M19.25M19.16M10.26M29.58M14.91M-53.84M51.78M
Net Income -106.53M-130.45M-84.55M-68.22M-174.26M-48.77M-35.45M-51.69M-268.49M-126.30M-46.29M-413.88M15.06M-457.19M-165.49M-37.12M131.54M-42.59M-55.47M-78.46M-91.41M369.51M-118.40M-124.97M-108.28M-83.58M174.28M-100.01M-84.42M-28.36M-44.55M-4.51M-48.80M-29.57M-37.73M-50.72M-64.98M-43.02M-114.73M-6.89M
Diluted EPS ------------------0.23-0.30-0.42-2.00-0.65-0.68-0.59-0.450.89-0.54-0.45-0.15-0.20-0.02-0.22-0.13-0.17-0.22-0.28-0.18-0.48-0.03

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 1.93B2.10B2.28B2.46B2.77B2.89B3.83B4.96B4.98B4.75B4.53B4.06B3.54B2.76B2.83B3.02B3.13B3.19B
Gross Profit -------1.45B1.44B1.25B1.07B876.54M797.15M500.95M594.41M746.70M799.31M837.55M
Operating Income -240.14M29.78M65.99M88.75M80.94M131.29M-84.91M-165.21M-31.08M-270.05M-594.25M-44.50M-97.69M-216.94M-42.69M18.41M46.53M13.50M
Net Income -373.24M-66.25M-48.90M-69.05M-66.47M-3.58M-148.99M-457.48M-404.40M-571.42M-528.26M-267.93M82.02M-99.29M-238.43M-189.01M-201.94M-262.69M
Diluted EPS -----------2.82-1.440.44-0.54-1.25-0.84-0.89-1.12

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --4.65B4.53B4.47B4.71B4.74B10.42B10.05B9.22B7.68B6.47B7.19B6.90B6.41B5.94B5.57B6.34B5.95B
Total Equity 1.42B960.60M1.09B1.06B1.04B996.99M1.02B2.88B2.46B2.08B1.53B1.02B696.36M800.43M697.40M582.61M403.66M212.47M-44.75M
Cash & Equivalents 100.90M53.97M66.37M81.83M30.84M69.24M58.51M104.08M88.03M216.40M222.65M398.27M240.23M380.42M347.03M398.85M277.97M308.93M279.12M
Long Term Debt --2.46B2.50B2.35B2.09B2.14B3.34B3.46B3.41B3.38B3.35B3.22B3.85B3.78B3.78B3.66B4.02B4.22B
Total Liabilities --3.56B3.47B3.43B3.71B3.72B7.54B7.59B7.14B6.15B5.45B6.50B6.10B5.71B5.35B5.17B6.12B6.00B
Current Liabilities --695.97M606.36M620.95M1.13B870.84M873.90M840.15M731.14M1.10B773.33M1.05B690.73M631.95M641.21M600.12M579.76M567.92M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 136.77M237.22M228.24M268.43M290.97M366.12M242.65M292.37M373.65M378.36M203.96M216.41M205.65M-94.63M3.28M162.92M166.18M218.03M
Investing Cash Flow -166.44M-351.43M-136.50M-203.90M-455.33M-264.81M-314.88M-568.98M171.80M-602.33M288.77M-225.54M-425.11M181.46M-67.43M-113.36M-278.07M-455.95M
Financing Cash Flow -17.26M126.61M-76.28M-115.52M202.77M-112.04M117.80M260.56M-422.11M229.20M-325.06M-139.39M382.91M-113.66M100.38M-174.44M142.06M201.09M
Capital Expenditure -189.03M-117.45M-93.68M-160.13M-208.41M-257.53M-304.25M-411.05M-333.65M-213.89M-225.47M-304.09M-185.87M-176.66M-196.92M-233.21M-201.25M-201.53M
Free Cash Flow -52.26M119.77M134.56M108.30M82.56M108.59M-61.59M-118.69M40.00M164.47M-21.51M-87.68M19.78M-271.29M-193.64M-70.28M-35.07M16.50M
Share Buybacks 29.19M0017.61M00009.64M04.26M23.95M18.12M00---

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------29.2%28.9%26.4%23.6%21.6%22.5%18.2%21.0%24.8%25.6%26.2%
Operating Margin % -12.5%1.4%2.9%3.6%2.9%4.5%-2.2%-3.3%-0.6%-5.7%-13.1%-1.1%-2.8%-7.9%-1.5%0.6%1.5%0.4%
Net Margin % -19.4%-3.2%-2.1%-2.8%-2.4%-0.1%-3.9%-9.2%-8.1%-12.0%-11.7%-6.6%2.3%-3.6%-8.4%-6.3%-6.5%-8.2%
ROE % -38.9%-6.1%-4.6%-6.7%-6.7%-0.4%-5.2%-18.6%-19.5%-37.3%-51.8%-38.5%10.2%-14.2%-40.9%-46.8%-95.0%587.0%
ROCE % -0.8%1.7%2.3%2.3%3.4%-0.9%-1.8%-0.4%-4.1%-10.4%-0.7%-1.6%-3.8%-0.8%0.4%0.8%0.3%

Shareholding Pattern

Insiders
1.96%
Institutions
112.89%
Public Float
115.15%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 9.51% 22.72M $361.42M
2 WCM Investment Management, LLC 5.37% 12.81M $203.84M
3 Deerfield Management Company, L.P 4.87% 11.64M $185.15M
4 Antipodes Partners Ltd. 4.78% 11.41M $181.48M
5 Vanguard Portfolio Management LLC 4.35% 10.39M $165.32M
6 Vanguard Capital Management LLC 4.23% 10.10M $160.75M
7 Wellington Management Group, LLP 3.70% 8.83M $140.49M
8 Carronade Capital Management, Lp 3.60% 8.59M $136.62M
9 Maple Rock Capital Partners, Inc. 3.42% 8.16M $129.78M
10 Renaissance Technologies, LLC 3.21% 7.66M $121.93M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BKD

Yahoo Finance Fri, 10 Jul 2026

Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4%

BKD's Q2 weighted average occupancy rises to 82.4% as steady resident demand and RevPAR growth expectations set the stage for its upcoming earnings.

Yahoo Finance Fri, 10 Jul 2026

1 Mooning Stock to Own for Decades and 2 That Underwhelm

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.…

Yahoo Finance hu, 09 Jul 2026

Brookdale Reports June 2026 Occupancy

Brookdale Senior Living Inc. (NYSE: BKD) reported today its occupancy for June 2026.

Yahoo Finance ue, 07 Jul 2026

Brookdale (BKD): Buy, Sell, or Hold Post Q1 Earnings?

Brookdale’s 38.6% return over the past six months has outpaced the S&P 500 by 30.6%, and its stock price has climbed to $15.59 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating …

Yahoo Finance Mon, 06 Jul 2026

Brookdale Announces Successful Financing Transactions; Extends 2027 Non-Recourse Mortgage Debt Maturity and Extends and Expands Credit Facility

Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or "the Company") announced today that the Company recently completed two financing transactions, proactively addressing another portion of its 2027 debt maturities while also expanding …

Yahoo Finance hu, 02 Jul 2026

1 Small-Cap Stock with Exciting Potential and 2 We Brush Off

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to t…

BKD — Frequently Asked Questions

What is the current share price of Brookdale Senior Living Inc. (BKD)?

As of 2026-07-14 21:23 PDT, Brookdale Senior Living Inc. (BKD) trades at $14.19 on NYSE. Its 52-week range is $7.13 to $16.77.

What is the market capitalisation of BKD?

Brookdale Senior Living Inc. (BKD) has a market capitalisation of $3.39B on NYSE.

What is the P/E ratio of BKD?

BKD trades at a trailing price-to-earnings (P/E) ratio of -16.31. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is -57.39.

Is BKD a good stock to buy?

This page provides a data-driven analysis of Brookdale Senior Living Inc. (BKD), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space